BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6048023)

  • 1. Use of competitive vitamin K antagonist, 2-chloro-3-phytyl-1,4-naphthoquinone, for the study of the mechanism of action of vitamin K and coumarin anticoagulants.
    Lowenthal J; MacFarlane JA
    J Pharmacol Exp Ther; 1967 Sep; 157(3):672-80. PubMed ID: 6048023
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulant-resistant rats: possible control by the use of the chloro analog of vitamin K 1 .
    Suttie JW
    Science; 1973 May; 180(4087):741-3. PubMed ID: 4702571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K and coumarin anticoagulants: dependence of anticoagulant effect on inhibition of vitamin K transport.
    Lowenthal J; Birnbaum H
    Science; 1969 Apr; 164(3876):181-3. PubMed ID: 5774189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the activity of the cis and trans isomer of vitamin K1 in vitamin K-deficient and coumarin anticoagulant-pretreated rats.
    Lowenthal J; Vergel Rivera GM
    J Pharmacol Exp Ther; 1979 Jun; 209(3):330-3. PubMed ID: 439009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative phosphorylation in mitochondria from animals treated with 2-chloro-3-phytyl-1,4-naphthoquinone, an antagonist of vitamin K-1.
    PARMAR SS; LOWENTHAL J
    Biochem Biophys Res Commun; 1962 Jun; 8():107-9. PubMed ID: 14483974
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitamin K requirement and warfarin tolerance in the hamster.
    Shah DV; Suttie JW
    Proc Soc Exp Biol Med; 1975 Oct; 150(1):126-8. PubMed ID: 1187683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant activity of a naphthoquinone analog of vitamin K and an inhibitor of coenzyme Q10- enzyme systems.
    Combs AB; Porter TH; Folkers K
    Res Commun Chem Pathol Pharmacol; 1976 Jan; 13(1):109-14. PubMed ID: 1257593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of action of naphthoquinones and hydroxycoumarins on the mechano-active properties of isolated coronary arteries].
    Lider VA; Shishkin SB; Feofilaktova SN
    Farmakol Toksikol; 1987; 50(5):31-4. PubMed ID: 3691774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chloro analog of vitamin K: antagonism of vitamin K action in normal and warfarin-resistant rats.
    Shah DV; Suttie JW
    Proc Soc Exp Biol Med; 1973 Jul; 143(3):775-9. PubMed ID: 4719463
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vitamin K: biochemistry, function, and deficiency. Review].
    Mijares ME; Nagy E; Guerrero B; Arocha-Piñango CL
    Invest Clin; 1998 Sep; 39(3):213-29. PubMed ID: 9780555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of vitamin K-deficiency and oral anticoagulants.
    Vermeer C; Hamulyák K
    Thromb Haemost; 1991 Jul; 66(1):153-9. PubMed ID: 1926045
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulant of indirect action nitropharin].
    Lakin KM; Smirnova TV; Karaseva MG
    Farmakol Toksikol; 1968; 31(2):184-7. PubMed ID: 5674673
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacology and therapeutics of vitamin K.
    Brace L
    Am J Med Technol; 1983 Jun; 49(6):457-63. PubMed ID: 6349360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)].
    Migne J; Monteil R; Pessereau G; Pernod J; Siau J
    Therapie; 1968; 23(3):553-66. PubMed ID: 5740621
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel oral anticoagulants and diet: the potential for interaction.
    Kamali F
    Am J Hematol; 2009 Apr; 84(4):260-1. PubMed ID: 19253346
    [No Abstract]   [Full Text] [Related]  

  • 16. A plasma factor enhances activity of vitamin K-dependent coagulation proteins.
    Owens MR; Cimino CD
    Thromb Haemost; 1983 Oct; 50(3):749-52. PubMed ID: 6648895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 3-amino-4-hydroxy coumarin and dihydroxy-phenyl coumarins as novel anticoagulants.
    Danis O; Yuce-Dursun B; Gunduz C; Ogan A; Sener G; Bulut M; Yarat A
    Arzneimittelforschung; 2010; 60(10):617-20. PubMed ID: 21125812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K deficiency amplifies anticoagulation response to ximelagatran: possible implications for direct thrombin inhibitors and their clinical safety.
    Kamali F; Wood P; Ward A
    Ann Hematol; 2009 Feb; 88(2):141-9. PubMed ID: 18716776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Constitutional specific effect of vitamin K1 and its analogs against coumarin compounds].
    ISLER O; RUEGG R; STUDER A; JURGENS R
    Hoppe Seylers Z Physiol Chem; 1953; 295():290-309. PubMed ID: 13128723
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of vitamin K epoxidase by two non-coumarin anticoagulants.
    Willingham AK; Laliberte RE; Bell RG; Matschiner JT
    Biochem Pharmacol; 1976 May; 25(9):1063-6. PubMed ID: 1267851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.